Company intelligence / Profile preview

ProChem

Rockford, Illinois, United States

Ownership: Private
Development stage: Other

Overview

ProChem supplied critical catalysts and high-purity materials for biomedical applications, including catalysts used in emergency remdesivir production for COVID-19; collaborates with pharma/biotech/academic labs

Modalities: Small moleculeInorganic compoundMetal-organic compound
Industry: Chemicals & Materials

Partnerships

Bayer AG (diagnostic system reagent)Lawrence Livermore National Laboratory (crystal for National Ignition Facility fusion)pharma clients in remdesivir supply chain

Beyond the preview

Go deeper on ProChem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProChem.

Explore the full profile